Rosa Anna DeFilippis

1.1k total citations
13 papers, 800 citations indexed

About

Rosa Anna DeFilippis is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Rosa Anna DeFilippis has authored 13 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Rosa Anna DeFilippis's work include Cancer-related Molecular Pathways (4 papers), Cancer Cells and Metastasis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Rosa Anna DeFilippis is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cancer Cells and Metastasis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Rosa Anna DeFilippis collaborates with scholars based in United States, China and Canada. Rosa Anna DeFilippis's co-authors include Daniel DiMaio, Edward C. Goodwin, Lingling Wu, Thea D. Tlsty, Hang Chang, Bahram Parvin, James J. Marx, Nancy Dumont, Joseph T. Rabban and Judy A. Tjoe and has published in prestigious journals such as Bioinformatics, Cancer Research and Journal of Virology.

In The Last Decade

Rosa Anna DeFilippis

13 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Anna DeFilippis United States 8 357 352 242 197 147 13 800
Hari Raghu United States 11 364 1.0× 260 0.7× 276 1.1× 112 0.6× 165 1.1× 11 790
Christopher W. Wasson United Kingdom 16 190 0.5× 324 0.9× 263 1.1× 172 0.9× 218 1.5× 34 795
Helene R. McMurray United States 9 175 0.5× 352 1.0× 197 0.8× 121 0.6× 100 0.7× 19 763
Sylvain Lefort France 15 380 1.1× 497 1.4× 196 0.8× 252 1.3× 258 1.8× 30 1.0k
Hongyi Pan United States 12 394 1.1× 326 0.9× 301 1.2× 87 0.4× 95 0.6× 21 861
Rüdiger Rüger Germany 16 240 0.7× 498 1.4× 177 0.7× 265 1.3× 96 0.7× 24 836
Francesca De Nicola Italy 18 236 0.7× 666 1.9× 402 1.7× 156 0.8× 151 1.0× 39 1.1k
Nathalie Britzen‐Laurent Germany 18 325 0.9× 426 1.2× 131 0.5× 113 0.6× 320 2.2× 40 981
Eun-Kyoung Yim South Korea 12 228 0.6× 591 1.7× 258 1.1× 143 0.7× 90 0.6× 13 882
Suruchi Mittal Italy 7 242 0.7× 331 0.9× 198 0.8× 143 0.7× 116 0.8× 7 641

Countries citing papers authored by Rosa Anna DeFilippis

Since Specialization
Citations

This map shows the geographic impact of Rosa Anna DeFilippis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Anna DeFilippis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Anna DeFilippis more than expected).

Fields of papers citing papers by Rosa Anna DeFilippis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Anna DeFilippis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Anna DeFilippis. The network helps show where Rosa Anna DeFilippis may publish in the future.

Co-authorship network of co-authors of Rosa Anna DeFilippis

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Anna DeFilippis. A scholar is included among the top collaborators of Rosa Anna DeFilippis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Anna DeFilippis. Rosa Anna DeFilippis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
DeFilippis, Rosa Anna, et al.. (2024). Overcoming Secondary Mutations of Type II Kinase Inhibitors. Journal of Medicinal Chemistry. 67(12). 9776–9788. 2 indexed citations
2.
3.
DeFilippis, Rosa Anna, et al.. (2023). An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L. European Journal of Medicinal Chemistry. 264. 115977–115977. 5 indexed citations
4.
DeFilippis, Rosa Anna, Colleen Fordyce, Kelley T. Patten, et al.. (2014). Stress Signaling from Human Mammary Epithelial Cells Contributes to Phenotypes of Mammographic Density. Cancer Research. 74(18). 5032–5044. 23 indexed citations
5.
Dumont, Nancy, Bob Liu, Rosa Anna DeFilippis, et al.. (2013). Breast Fibroblasts Modulate Early Dissemination, Tumorigenesis, and Metastasis through Alteration of Extracellular Matrix Characteristics. Neoplasia. 15(3). 249–IN7. 151 indexed citations
6.
DeFilippis, Rosa Anna, Hang Chang, Nancy Dumont, et al.. (2012). CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues. Cancer Discovery. 2(9). 826–839. 152 indexed citations
7.
Tlsty, Thea D., et al.. (2012). Cell-extrinsic consequences of epithelial stress: Activation of protumorigenic tissue phenotypes - eScholarship. 2 indexed citations
8.
Chang, Hang, et al.. (2008). Scoring histological sections through immunohistochemistry. 344–347. 1 indexed citations
9.
Chang, Hang, Rosa Anna DeFilippis, Thea D. Tlsty, & Bahram Parvin. (2008). Graphical methods for quantifying macromolecules through bright field imaging. Bioinformatics. 25(8). 1070–1075. 12 indexed citations
10.
11.
12.
DeFilippis, Rosa Anna, Edward C. Goodwin, Lingling Wu, & Daniel DiMaio. (2002). Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells. Journal of Virology. 77(2). 1551–1563. 267 indexed citations
13.
Naeger, Lisa K., Edward C. Goodwin, Eun Seong Hwang, et al.. (1999). Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.. PubMed. 10(6). 413–22. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hari Raghu Breakdown of academic impact, for papers by Christopher W. Wasson Breakdown of academic impact, for papers by Helene R. McMurray Breakdown of academic impact, for papers by Sylvain Lefort Breakdown of academic impact, for papers by Hongyi Pan Breakdown of academic impact, for papers by Rüdiger Rüger Breakdown of academic impact, for papers by Francesca De Nicola Breakdown of academic impact, for papers by Nathalie Britzen‐Laurent Breakdown of academic impact, for papers by Eun-Kyoung Yim Breakdown of academic impact, for papers by Suruchi Mittal
Rankless by CCL
2026